NCT00618176

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 198 (actual)
• Sponsor: Peking Union Medical College · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the three generic nevirapine-based antiretroviral regimens are effective in the treatment of Acquired immune deficiency syndrome .

Conditions

• HIV Infections

Interventions

Type	Name	Description
DRUG	Zidovudine (AZT)+ Didanosine (ddI)+ Nevirapine (NVP)	Zidovudine (AZT) 300mg bid Didanosine (ddI) 200mg bid (W\>60Kg)125mg bid (W\<60Kg) Nevirapine (NVP) 200mg bid
DRUG	Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP)	Stavudine (d4T) 30mg bid (W\>60Kg)20mg bid (W\<60Kg) Lamivudine (3TC)300mg qd Nevirapine (NVP)200mg bid
DRUG	Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP)	Zidovudine (AZT) 300mg bid Lamivudine (3TC) 300mg qd Nevirapine (NVP) 200mg bid

Timeline

• Start date: 2005-01-01
• Primary completion: 2006-09-01
• First posted: 2008-02-18
• Last updated: 2008-03-24

Locations

1 site across 1 country: China